| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $58.40K | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | – |
| Gross Profit | $0.00 | $0.00 | $58.40K | $0.00 | – |
| Operating Expenses | $87.40K | $82.88K | $430.38K | $472.80K | $286.48K |
| R&D | – | – | – | – | – |
| SG&A | $45.35K | $45.29K | $369.67K | $416.28K | $211.43K |
| Operating Income | -$87.40K | -$82.88K | -$371.99K | -$472.80K | -$286.48K |
| Interest Expense | – | – | – | $1.00 | $1.00 |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $29.44K | -$65.46K | -$371.08K | -$473.22K | -$286.31K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | 0.0000 | 0.0000 | – | – | – |
| Shares (diluted) | $121.98M | $121.98M | – | – | – |